At the 2019 edition of the Biomanufacturing World Summit series earlier this month in San Diego we spoke with Laks Pernenkil, Principal | Life Sciences Operations with Deloitte Consulting LLP. Laks shared his insights into digital transformation in general, and specifically how the ‘Smart Factory’ will change the way biopharmaceutical companies operate.
—
Innovation starts with insight and seeing challenges in a new way. Amid unprecedented uncertainty and change, life sciences stakeholders are looking for new ways to transform their organizations using digital innovation and technologies. Deloitte’s team of thinkers and doers can help you imagine, deliver, and run your digital manufacturing operations and supply networks to address tomorrow’s challenges and opportunities—providing a platform to help generate critical insights, optimize business processes, and automate manufacturing and supply chain activities. Our global life sciences and health care practice of more than 12,400 helps clients transform uncertainty into possibility and rapid change into lasting progress. Comprehensive consulting, financial advisory, risk management, audit, tax and related capabilities deliver value at every step, from insight to strategy to action. Learn more: www.deloitte.com/us/lifesciences
